VistaGen Therapeutics Inc (VTGN) — Cash Flow-to-Debt Ratio
VistaGen Therapeutics Inc (VTGN) has a Cash Flow-to-Debt Ratio of -1.24x as of March 2026, meaning its operating cash flow of $-16.20 Million could theoretically repay -1% of its total liabilities ($13.04 Million) in one year. Check how aggressively does VistaGen Therapeutics Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
VistaGen Therapeutics Inc Cash Flow-to-Debt Ratio (2008–2026)
Historical debt coverage capacity for VistaGen Therapeutics Inc across 19 annual periods. Also explore total assets of VistaGen Therapeutics Inc for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for VistaGen Therapeutics Inc (2008–2026)
Year-by-year debt coverage analysis for VistaGen Therapeutics Inc. For market capitalisation and broader financial context, see VistaGen Therapeutics Inc stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2026 | -5.09x | $-66.44 Million | $13.04 Million | ▼ -68.8% |
| 2025 | -3.02x | $-42.10 Million | $13.95 Million | ▼ -9.5% |
| 2024 | -2.76x | $-25.81 Million | $9.37 Million | ▲ +50.1% |
| 2023 | -5.52x | $-49.72 Million | $9.01 Million | ▼ -21.1% |
| 2022 | -4.56x | $-45.26 Million | $9.93 Million | ▼ -515.5% |
| 2021 | -0.74x | $-12.07 Million | $16.30 Million | ▲ +45.9% |
| 2020 | -1.37x | $-15.76 Million | $11.50 Million | ▲ +34.6% |
| 2019 | -2.09x | $-14.53 Million | $6.94 Million | ▼ -0.8% |
| 2018 | -2.08x | $-9.06 Million | $4.36 Million | ▲ +11.5% |
| 2017 | -2.35x | $-7.26 Million | $3.10 Million | ▼ -93.5% |
| 2016 | -1.21x | $-4.81 Million | $3.97 Million | ▼ -811.1% |
| 2015 | -0.13x | $-2.77 Million | $20.81 Million | ▲ +18.3% |
| 2014 | -0.16x | $-2.13 Million | $13.06 Million | ▲ +36.9% |
| 2013 | -0.26x | $-3.46 Million | $13.44 Million | ▲ +56.3% |
| 2012 | -0.59x | $-3.57 Million | $6.05 Million | ▲ +72.6% |
| 2011 | -2.15x | $-6.88K | $3.20K | ▲ +85.8% |
| 2010 | -15.17x | $-22.76K | $1.50K | ▼ -182.3% |
| 2009 | -5.37x | $-14.43K | $2.69K | ▲ +73.2% |
| 2008 | -20.06x | $-4.81K | $240.00 | — |